Skip to main content
S 1217 118th Congress Senate

Ending the Prescription Drug Kickback Act of 2023

Official title: A bill to prohibit the distribution and receipt of rebates for prescription drugs.

Introduced: April 19, 2023 Introduced by: Hawley, Josh Republican · Missouri See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 19, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 19, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 19, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Ending the Prescription Drug Kickback Act of 2023

This bill generally prohibits prescription drug manufacturers from providing rebates to pharmacy benefit managers (PBMs) or private health insurance plans.

Specifically, the bill eliminates the safe harbor for rebates, or other payments, provided to PBMs that are intended to influence the applicable cost-sharing tier of the drug (e.g., placing the drug in a more favorable formulary tier).

The bill further prohibits health insurance plans from receiving such rebates with respect to a prescription drug covered by the plan. Plans also must ensure PBMs do not receive any such rebates.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1217: Ending the Prescription Drug Kickback Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-1217/
MLA
"S. 1217: Ending the Prescription Drug Kickback Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-1217/.
Bluebook (legal)
S. 1217, 118th Cong. (2026), https://openamerica.io/bill/118-S-1217/.
Markdown link
[S. 1217: Ending the Prescription Drug Kickback Act of 2023](https://openamerica.io/bill/118-S-1217/)
Report a problem